Edition:
United States

Insider Trading: Achillion Pharmaceuticals Inc (ACHN.O)

ACHN.O on Nasdaq

8.60USD
22 Jul 2016
Change (% chg)

$-0.17 (-1.94%)
Prev Close
$8.77
Open
$8.76
Day's High
$8.84
Day's Low
$8.56
Volume
926,612
Avg. Vol
1,442,102
52-wk High
$10.95
52-wk Low
$5.57

TREU JESSE I

Institutional Holders

% Shares Owned: 86.27%
# of Holders: 219
Total Shares Held: 117,882,395
3 Mo. Net Change: -104,828
# New Positions: 3
# Closed Positions: 1
# Increased Positions: 12
# Reduced Positions: 6
# Net Buyers: 6

Officers & Directors

Name Age Since Current Position

David Scheer

63 2010 Chairman of the Board

Milind Deshpande

59 2013 President, Chief Executive Officer, Director

Mary Fenton

51 2015 Chief Financial Officer, Executive Vice President

Joel Barrish

58 2016 Executive Vice President, Chief Scientific Officer

Martha Manning

61 2016 Executive Vice President, General Counsel, Corporate Secretary

David Apelian

50 2013 Executive Vice President, Chief Medical Officer

Joseph Truitt

51 2014 Executive Vice President, Chief Commercial Officer

Amy Jennings

2016 Senior Vice President - Regulatory Affairs

Michael Kishbauch

66 2013 Director

Frank Verwiel

54 2015 Director

Jason Fisherman

58 2000 Independent Director

Gary Frashier

78 2008 Independent Director

Kurt Graves

48 2012 Independent Director

Robert Van Nostrand

58 2007 Independent Director

Nicole Vitullo

58 2010 Independent Director